
Carin A. De Groot-Uyl
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications
Principles of selecting cost-effectiveness thresholds in price-taker countries.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: August 07, 2026
Caregiver Preferences for AI-Supported Telemedicine in Pediatric Palliative Care: A Discrete Choice Experiment.
Journal: Journal of palliative care
Published: June 10, 2026
From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Drugs - real world outcomes
Published: March 10, 2026
Legal implications of joint clinical assessments under the EU HTA regulation.
Journal: Health economics, policy, and law
Published: March 02, 2026
Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 26, 2025
Challenges and Potential Solutions to Advance Global Cancer Drug Development.
Journal: Therapeutic innovation & regulatory science
Published: October 14, 2025
Involvement in the Shadows: A Qualitative Interview Study on Informal Caregiver Involvement in the Formal Care Trajectories of Individuals Living with Severe Mental Health Problems.
Journal: Community mental health journal
Published: October 07, 2025
Reply to comment on Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study.
Journal: Clinical and translational radiation oncology
Published: July 09, 2025
Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models.
Journal: Orphanet journal of rare diseases
Published: May 01, 2025
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.
Journal: HemaSphere
Published: April 29, 2025
Last Updated: 09/26/2026